|Podcasts|September 17, 2020
Episode 65: Creating a Path for Innovation
Author(s)Elaine Quilici
George Baxter, CEO of Edinburgh Innovations, is here to discuss the company's commercialization model, and how his group is bringing innovation to market in Scotland.
Advertisement
George Baxter, CEO of Edinburgh Innovations, is here to discuss the company's commercialization model, and how his group is bringing innovation to market in Scotland.
You can listen and/or download the episode on SoundCloud, or directly through iTunes, GooglePlay, Stitcher, and Overcast.
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
From Ambition to Advantage: How Life Sciences Leaders Are Scaling AI
2
Lilly’s Retatrutide Displays Positive Topline Results in Successful Phase III Trial
3
EU Opportunities: How EMA Support Programs Can Slash Drug Market Entry Costs by 90%
4
Augmentin XR Becomes First Approval Under Commissioner’s National Priority Voucher Pilot Program
5
